POC Biosensor for Periodontitis
用于牙周炎的 POC 生物传感器
基本信息
- 批准号:9905270
- 负责人:
- 金额:$ 22.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-02 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:ADORA2A geneAdenosineAffectAnti-Inflammatory AgentsAspartate TransaminaseBMP2 geneBindingBiologicalBiological MarkersBiosensorCD100 antigenCalculiCaringCellsClinicalCollectionConsumptionDetectionDevelopmentDevicesDiagnosisDiseaseElderlyEndothelial CellsEnzyme-Linked Immunosorbent AssayEnzymesEvaluationFutureGingivaGingival IndexesGingivitisHealthHemorrhageImmuneInflammationInflammation MediatorsInflammatoryInflammatory ResponseInterleukin-1 betaLab-On-A-ChipsLesionLigationLiquid substanceMMP8 geneMeasurementMeasuresMental RetardationMonitorOral cavityOsteogenesisOutcomeP2X-receptorPaperPathogenicityPatientsPeriodontal PocketPeriodontitisPeriodontiumPlant RootsPopulationPrediction of Response to TherapyPredictive ValueProceduresProductionRegenerative responseRegulatory T-LymphocyteReportingRisk FactorsRoleSamplingSeriesSeveritiesSiteStandardizationStudy SubjectSumTNF geneTemporomandibular JointTestingTimeTissuesTooth structureagedbasebiomarker panelbonecell injurycohortcollagenasecytokineextracellularhealingneutrophilnext generationnovelnovel strategiesoperationosteogenicoutcome forecastperiapicalreceptorrecruitregenerativeresponsetissue regenerationtooltooth crowdingtreatment response
项目摘要
For nearly a century, practitioners have typically relied on periodontal probing to diagnose periodontitis. Based
on a strong positive correlation between pocket depth and severity of periodontitis, the primary purpose of
periodontal probing is to measure pocket depths around a tooth in order to establish the state of health of the
periodontium. However, periodontal probing is a time-consuming chairside procedure and has little predictive
value in determining current disease activity, prognosis of future progression, or healing in response to treatment,
essentially because scant quantitative biological information gained from measuring pocket depth. In this study,
we will use “lab-on-a-chip” device, SMARTChip® Biosensor, to measure extracellular ATP (eATP) and
extracellular Adenosine (eADO) in GCF. More specifically, GCF collected from patients using a paper point will
be diluted into PBS and immediately applied to SMARTChip at chairside. Unlike other subjective POC devices,
enzyme-based amperometric SMARTChip® can quantify eATP and eADO in GCF.
Recent studies have demonstrated that eATP released from damaged cells or activated neutrophils is causal
for inflammatory responses by binding with a series of purinergic P2X and P2Y receptors. This eATP induces
proinflammatory factors, such as TNF-α and IL-1β, from innate immune cells, suggesting that eATP is an early-
response inflammatory mediator. Meanwhile, ectonucleotidases, CD39 and CD73, produced by Treg and Breg
cells, as well as endothelial cells convert ATP to anti-inflammatory eADO. We have learned that eADO, by
ligation with its specific ADO receptor, suppresses inflammation by down-modulating TNF-α and IL-1β
expressions, and promotes the production of BMP2. These lines of evidence suggest that eATP is associated
with inflammation, but that eADO may function as an anti-inflammatory and pro-osteogenesis factor in
periodontitis. Our hypothesis holds that SMARTChip® measurements of eATP/eADO in GCF will serve to
determine inflammatory status in periodontitis lesion and act as a predictor of bone regenerative responses. In
order to test this hypothesis we will validate POC SMARTChip® measurements of eATP and eADO in GCF for
the diagnosis periodontitis and prediction of treatment-related bone regenerative activities. Three cohorts will be
recruited for this study; A) control healthy subjects, B) gingivitis patients and C) periodontitis patients.
Conventional periodontal measurements (pocket depth, clinical attachment loss, bleeding on probing and
gingival index) and standardized periapical radiograph will be performed. Then, GCF will be collected by a
PerioPaper (GCF Collection Strip) at the deepest periodontal pocket or gingival crevice from each quadrant, and
the concentrations of eATP and eADO will be monitored at chairside using a SMARTChip®. A panel of
biomarkers will be monitored in GCF using Luminex® Multiplex which will be compared to eATP/eADO for
correlation with the clinical measurements of pocket depth and clinical attachment loss as well as treatment-
related bone regenerative activities in the study subjects.
近一个世纪以来,医生通常依靠牙周探诊来诊断牙周炎。
牙周袋深度与牙周炎严重程度之间存在很强的正相关性,其主要目的是
牙周探诊是测量牙齿周围的牙周袋深度,以确定牙齿的健康状况
然而,牙周探查是一项耗时的椅旁手术,并且几乎没有预测性。
在确定当前疾病活动、未来进展的预后或治疗后的愈合方面的价值,
主要是因为在这项研究中,通过测量口袋深度获得的定量生物信息很少。
我们将使用“芯片实验室”设备 SMARTChip® 生物传感器来测量细胞外 ATP (eATP) 和
GCF 中的细胞外腺苷 (eADO) 更具体地说,使用纸点从患者身上收集 GCF。
与其他主观 POC 设备不同,可稀释到 PBS 中并立即应用于 SMARTChip。
基于酶的电流分析 SMARTChip® 可以量化 GCF 中的 eATP 和 eADO。
最近的研究表明,受损细胞或活化的中性粒细胞释放的 eATP 是导致
该 eATP 通过与一系列嘌呤能 P2X 和 P2Y 受体结合来诱导炎症反应。
来自先天免疫细胞的促炎因子,例如 TNF-α 和 IL-1β,表明 eATP 是一种早期
同时,Treg 和 Breg 产生的核酸外切酶 CD39 和 CD73。
细胞以及内皮细胞将 ATP 转化为抗炎 eADO。
与其特异性 ADO 受体连接,通过下调 TNF-α 和 IL-1β 抑制炎症
这些证据表明 eATP 相关。
与炎症有关,但 eADO 可能作为抗炎和促骨生成因子
我们的假设认为,GCF 中 eATP/eADO 的 SMARTChip® 测量将有助于
确定牙周炎病变的炎症状态并作为骨再生反应的预测因子。
为了检验这一假设,我们将验证 GCF 中 eATP 和 eADO 的 POC SMARTChip® 测量结果
牙周炎的诊断和治疗相关骨再生活动的预测将分为三个队列。
本研究招募的受试者;A) 对照健康受试者,B) 牙龈炎患者和 C) 牙周炎患者。
常规牙周测量(牙周袋深度、临床附着丧失、探诊出血和
然后,将进行牙龈指数)和标准化根尖X光检查,GCF将被收集。
PerioPaper(GCF 收集条)位于每个象限最深的牙周袋或牙龈缝隙,以及
eATP 和 eADO 的浓度将在椅旁使用 SMARTChip® 面板进行监测。
将使用 Luminex® Multiplex 在 GCF 中监测生物标志物,并将其与 eATP/eADO 进行比较
与袋深度和临床附着丧失以及治疗的临床测量的相关性
研究对象中相关的骨再生活动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TOSHIHISA KAWAI其他文献
TOSHIHISA KAWAI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TOSHIHISA KAWAI', 18)}}的其他基金
Osteoimmunology of Retarded Bone Regeneration in Periodontitis
牙周炎骨再生迟缓的骨免疫学
- 批准号:
10451354 - 财政年份:2021
- 资助金额:
$ 22.53万 - 项目类别:
Osteoimmunology of Retarded Bone Regeneration in Periodontitis
牙周炎骨再生迟缓的骨免疫学
- 批准号:
10451355 - 财政年份:2021
- 资助金额:
$ 22.53万 - 项目类别:
Osteoimmunology of Retarded Bone Regeneration in Periodontitis
牙周炎骨再生迟缓的骨免疫学
- 批准号:
10219233 - 财政年份:2020
- 资助金额:
$ 22.53万 - 项目类别:
Osteoimmunology of Retarded Bone Regeneration in Periodontitis
牙周炎骨再生迟缓的骨免疫学
- 批准号:
10449982 - 财政年份:2020
- 资助金额:
$ 22.53万 - 项目类别:
Role of platelets in periodontal bone remodeling.
血小板在牙周骨重塑中的作用。
- 批准号:
10087691 - 财政年份:2020
- 资助金额:
$ 22.53万 - 项目类别:
Osteoimmunology of Retarded Bone Regeneration in Periodontitis
牙周炎骨再生迟缓的骨免疫学
- 批准号:
10667111 - 财政年份:2020
- 资助金额:
$ 22.53万 - 项目类别:
Osteoimmunology of Retarded Bone Regeneration in Periodontitis
牙周炎骨再生迟缓的骨免疫学
- 批准号:
10672563 - 财政年份:2020
- 资助金额:
$ 22.53万 - 项目类别:
Osteoimmunology of Retarded Bone Regeneration in Periodontitis
牙周炎骨再生迟缓的骨免疫学
- 批准号:
10674478 - 财政年份:2020
- 资助金额:
$ 22.53万 - 项目类别:
Osteoimmunology of Retarded Bone Regeneration in Periodontitis
牙周炎骨再生迟缓的骨免疫学
- 批准号:
10885237 - 财政年份:2020
- 资助金额:
$ 22.53万 - 项目类别:
相似国自然基金
遗传变异调控可变多聚腺苷酸化影响胰腺癌风险的分子流行病学研究
- 批准号:82373663
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
非小细胞肺癌肿瘤微环境中CD39+CD69+终末CD8+T细胞通过腺苷通路影响Th细胞功能的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
腺苷异常积累影响糖尿病伤口修复的分子机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
选择性多聚腺苷酸化关联的遗传变异对肺腺癌发病风险的影响及机制研究
- 批准号:82273715
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
DNA甲基化对选择性多聚腺苷酸化的影响及在肝癌复发中的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:54.7 万元
- 项目类别:面上项目
相似海外基金
A Role for the Orphan Receptor, GPR37, in Estradiol-induced Changes in Sleep-Wake States
孤儿受体 GPR37 在雌二醇诱导的睡眠-觉醒状态变化中的作用
- 批准号:
10677913 - 财政年份:2023
- 资助金额:
$ 22.53万 - 项目类别:
Targeting the CD73-adenosinergic pathway in head and neck cancer
靶向头颈癌中的 CD73 腺苷能通路
- 批准号:
10813613 - 财政年份:2023
- 资助金额:
$ 22.53万 - 项目类别:
Novel mechanisms regulating adipose tissue function in health and disease
调节健康和疾病中脂肪组织功能的新机制
- 批准号:
10736765 - 财政年份:2023
- 资助金额:
$ 22.53万 - 项目类别:
Therapies for epilepsy prevention - focus on adenosine
预防癫痫的疗法——关注腺苷
- 批准号:
10655634 - 财政年份:2022
- 资助金额:
$ 22.53万 - 项目类别: